Functioning as a triple agonist of the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide 1 (GLP-1), and glucagon receptors, retatrutide is poised to redefine weight management
Professor Andy Schmelz speaks out about Thyroid cancer Andy Schmelz is an associate professor of pharmacy practice at Butler University
Introduction Obesity is a global health problem and increases the risk of developing type II diabetes mellitus (T2DM), cardiovascular disease, and dyslipidemia
One of the biggest misconceptions surrounding tirzepatide is that every patient should increase from 2.5 mg to 5 mg after exactly four weeks
Conclusion: Which One Should You Choose
GLP-1 produced in the gut sends signals to the brain, influencing various functions, including mood regulation